Article
Implementing cell-free DNA of pancreatic cancer patient–derived organoids for personalized oncology
2 Jul 2020
Abstract excerpt
One of the major challenges in using pancreatic cancer patient-derived organoids (PDOs) in precision oncology is the time from biopsy to functional characterization. This is particularly true for endoscopic ultrasound-guided fine-needle aspiration biopsies, typically resulting in specimens with limited tumor cell yield. Here, we tested conditioned media of individual PDOs for cell-free DNA to detect driver...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
